PREDAIR

Pre-Launch

prednisolone sodium phosphate

ANDAOPHTHALMICSOLUTION/DROPS

Lifecycle

Pre-Launch

Data completeness

2/8 — Basic

PREDAIR (prednisolone sodium phosphate) by Alcon is clinical pharmacology naturally occurring glucocorticoids (hydrocortisone), which also have salt-retaining properties, are used as replacement therapy in adrenocortical deficiency states. Approved for the following conditions: 1, systemic lupus erythematosus, dermatomyositis (polymyositis) and 11 more indications.

Drug data last refreshed 1mo ago

Mechanism of Action

CLINICAL PHARMACOLOGY Naturally occurring glucocorticoids (hydrocortisone), which also have salt-retaining properties, are used as replacement therapy in adrenocortical deficiency states. Their synthetic analogs are primarily used for their potent anti-inflammatory effects in disorders of many…

Worked on PREDAIR at Alcon? Share your interview experience or compensation data (+7 days Pro)

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.

PREDAIR

Mechanism of Action

Indications (14)